Literature DB >> 24510874

Induction of brain arteriovenous malformation in the adult mouse.

Wanqiu Chen1, William L Young, Hua Su.   

Abstract

Brain arteriovenous malformations (bAVM) are tangles of abnormal, dilated vessels that directly shunt blood between the arteries and veins. The pathogenesis of bAVM is currently unknown. Patients with hereditary hemorrhagic telangiectasia (HHT) have a higher prevalence of bAVM than the general population. Animal models are important tools for dissecting the disease etiopathogenesis and for testing new therapies. Here, we introduce a method that induces the bAVM phenotype through regional deletion of activin-like kinase 1 (Alk1, the causal gene for HHT2) and vascular endothelial growth factor (VEGF) stimulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24510874      PMCID: PMC3988785          DOI: 10.1007/978-1-4939-0320-7_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  21 in total

1.  Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.

Authors:  H Su; R Lu; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain.

Authors:  Fanxia Shen; Hua Su; Weizhong Liu; Yuet W Kan; William L Young; Guo-Yuan Yang
Journal:  Front Biosci       Date:  2006-09-01

3.  Differences in the cerebrovascular anatomy of C57black/6 and SV129 mice.

Authors:  K Maeda; R Hata; K A Hossmann
Journal:  Neuroreport       Date:  1998-05-11       Impact factor: 1.837

4.  Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm.

Authors:  Helen Kim; Hua Su; Shantel Weinsheimer; Ludmila Pawlikowska; William L Young
Journal:  Acta Neurochir Suppl       Date:  2011

5.  Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain.

Authors:  Wanqiu Chen; Yi Guo; Espen J Walker; Fanxia Shen; Kristine Jun; S Paul Oh; Vincent Degos; Michael T Lawton; Tarik Tihan; Dimitrios Davalos; Katerina Akassoglou; Jeffrey Nelson; John Pile-Spellman; Hua Su; William L Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

6.  Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population.

Authors:  Rodney A Gabriel; Helen Kim; Stephen Sidney; Charles E McCulloch; Vineeta Singh; S Claiborne Johnston; Nerissa U Ko; Achal S Achrol; Jonathan G Zaroff; William L Young
Journal:  Stroke       Date:  2009-11-19       Impact factor: 7.914

7.  Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor.

Authors:  Lise K Sorensen; Benjamin S Brooke; Dean Y Li; Lisa D Urness
Journal:  Dev Biol       Date:  2003-09-01       Impact factor: 3.582

8.  ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.

Authors:  Sung O Park; Young Jae Lee; Tsugio Seki; Kwon-Ho Hong; Naime Fliess; Zhigang Jiang; Alice Park; Xiaofang Wu; Vesa Kaartinen; Beth L Roman; S Paul Oh
Journal:  Blood       Date:  2007-10-02       Impact factor: 22.113

9.  Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia.

Authors:  Sung Ok Park; Mamta Wankhede; Young Jae Lee; Eun-Jung Choi; Naime Fliess; Se-Woon Choe; Seh-Hoon Oh; Glenn Walter; Mohan K Raizada; Brian S Sorg; S Paul Oh
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

10.  Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse.

Authors:  Eun-Jung Choi; Espen J Walker; Fanxia Shen; S Paul Oh; Helen M Arthur; William L Young; Hua Su
Journal:  Cerebrovasc Dis       Date:  2012-05-09       Impact factor: 2.762

View more
  7 in total

1.  Induction of Brain Arteriovenous Malformation Through CRISPR/Cas9-Mediated Somatic Alk1 Gene Mutations in Adult Mice.

Authors:  Wan Zhu; Daniel Saw; Miriam Weiss; Zhengda Sun; Meng Wei; Sonali Shaligram; Sen Wang; Hua Su
Journal:  Transl Stroke Res       Date:  2018-12-03       Impact factor: 6.829

2.  Persistent infiltration and pro-inflammatory differentiation of monocytes cause unresolved inflammation in brain arteriovenous malformation.

Authors:  Rui Zhang; Zhenying Han; Vincent Degos; Fanxia Shen; Eun-Jung Choi; Zhengda Sun; Shuai Kang; Michael Wong; Wan Zhu; Lei Zhan; Helen M Arthur; S Paul Oh; Marie E Faughnan; Hua Su
Journal:  Angiogenesis       Date:  2016-06-20       Impact factor: 9.596

Review 3.  Targeting BMP signalling in cardiovascular disease and anaemia.

Authors:  Nicholas W Morrell; Donald B Bloch; Peter ten Dijke; Marie-Jose T H Goumans; Akiko Hata; Jim Smith; Paul B Yu; Kenneth D Bloch
Journal:  Nat Rev Cardiol       Date:  2015-10-13       Impact factor: 32.419

4.  Arteriovenous malformations: the newest Sonic hedgehog game in the postnatal brain.

Authors:  Igor Giarretta; Roberto Pola
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

5.  Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges.

Authors:  Simon Tual-Chalot; S Paul Oh; Helen M Arthur
Journal:  Front Genet       Date:  2015-02-18       Impact factor: 4.599

6.  Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.

Authors:  Angela M Crist; Amanda R Lee; Nehal R Patel; Dawn E Westhoff; Stryder M Meadows
Journal:  Angiogenesis       Date:  2018-02-19       Impact factor: 9.596

7.  Morphometric characterization of brain arteriovenous malformations for clinical and radiological studies to identify silent intralesional microhemorrhages.

Authors:  Melike Pekmezci; Jeffrey Nelson; Hua Su; Christopher Hess; Michael T Lawton; Melda Sonmez; William L Young; Helen Kim; Tarik Tihan
Journal:  Clin Neuropathol       Date:  2016 May-Jun       Impact factor: 1.368

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.